Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Rapid Micro Biosystems, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −1 vs. Q2 2023
- Shares held
- 21.5M
- −416.4K (−1.9%) vs. Q2 2023
- Total value
- $23.2M
- +$1.30M (+5.9%) vs. Q2 2023
- New holders
- 1
- 4 more added
- Sold out
- 2
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $9.11M | 1.02% | 00.0% | Unchanged |
| Kennedy Lewis Management LP | 4,939,931 | $5.34M | 25.51% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,434,228 | $1.55M | 0.00% | −1,479−0.1% | Reduced |
| Glenview Capital Management, LLC | 1,318,288 | $1.42M | 0.04% | 00.0% | Unchanged |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,038,296 | $1.12M | 5.38% | 00.0% | Unchanged |
| BlackRock Inc. | 1,022,118 | $1.10M | 0.00% | −12,743−1.2% | Reduced |
| Goldman Sachs Group Inc | 947,781 | $1.02M | 0.00% | +6,424+0.7% | Added |
| Vanguard Group Inc | 726,024 | $784.1K | 0.00% | −3,576−0.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 700,000 | $756.0K | 0.00% | 00.0% | Unchanged |
| Advent International Corp | 577,777 | $624.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 155,264 | $167.7K | 0.00% | +58,616+60.6% | Added |
| State Street Corp | 26,074 | $28.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 24,985 | $27.0K | 0.00% | −18,787−42.9% | Reduced |
| Parkwood LLC | 24,511 | $26.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 22,387 | $24.0K | 0.00% | −5,379−19.4% | Reduced |
| Northern Trust Corp | 18,944 | $20.5K | 0.00% | −2,571−11.9% | Reduced |
| Citadel Advisors LLC | 16,641 | $18.0K | 0.00% | −33,095−66.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 15,000 | $16.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10,644 | $11.5K | 0.00% | +436+4.3% | Added |
| Tower Research Capital LLC (TRC) | 3,152 | $3.40K | 0.00% | −710−18.4% | Reduced |
| Resources Management Corp | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 146 | $158 | 0.00% | +62+73.8% | Added |
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% | +4 | New |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −403,284−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −339−100.0% | Sold out |